GIP/GLP-1 Dual Agonists: Special-Populations Prescribing Summary
Evidence-based prescribing guide for tirzepatide and other GIP/GLP-1 dual agonists in renal impairment, hepatic disease, older adults, adolescents, pregnancy, and heart failure with preserved ejection fraction.
Read clinical review